Sherwin-Williams (NYSE:SHW) PT Raised to $310.00 at Robert W. Baird

Sherwin-Williams (NYSE:SHW) had its price objective lifted by stock analysts at Robert W. Baird from $300.00 to $310.00 in a research note issued to investors on Wednesday, Benzinga reports. The brokerage presently has a “neutral” rating on the specialty chemicals company’s stock. Robert W. Baird’s price objective points to a potential upside of 2.53% from the stock’s previous close.

A number of other brokerages have also recently weighed in on SHW. Barclays boosted their price target on Sherwin-Williams from $285.00 to $315.00 and gave the stock an “equal weight” rating in a research report on Monday, January 29th. Citigroup boosted their price target on Sherwin-Williams from $360.00 to $390.00 and gave the stock a “buy” rating in a research report on Wednesday, April 10th. Mizuho reduced their price target on Sherwin-Williams from $352.00 to $340.00 and set a “buy” rating for the company in a research report on Friday, January 26th. Royal Bank of Canada reduced their price target on Sherwin-Williams from $346.00 to $341.00 and set an “outperform” rating for the company in a research report on Friday, January 26th. Finally, Evercore ISI dropped their price objective on Sherwin-Williams from $385.00 to $380.00 and set an “outperform” rating on the stock in a research note on Tuesday, April 16th. One investment analyst has rated the stock with a sell rating, six have given a hold rating and thirteen have assigned a buy rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $326.50.

Sherwin-Williams Price Performance

SHW opened at $302.34 on Wednesday. The stock has a market cap of $76.93 billion, a price-to-earnings ratio of 32.69, a PEG ratio of 2.45 and a beta of 1.15. Sherwin-Williams has a 1 year low of $221.76 and a 1 year high of $348.37. The company has a current ratio of 0.83, a quick ratio of 0.48 and a debt-to-equity ratio of 2.25. The stock has a fifty day moving average price of $328.40 and a 200 day moving average price of $298.73.

Sherwin-Williams (NYSE:SHW) last released its quarterly earnings data on Tuesday, April 23rd. The specialty chemicals company reported $2.17 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $2.22 by ($0.05). Sherwin-Williams had a net margin of 10.36% and a return on equity of 74.72%. The firm had revenue of $5.37 billion for the quarter, compared to analyst estimates of $5.50 billion. During the same period in the previous year, the business posted $2.04 EPS. Sherwin-Williams’s revenue for the quarter was down 1.4% on a year-over-year basis. Analysts forecast that Sherwin-Williams will post 11.46 EPS for the current fiscal year.

Insider Buying and Selling at Sherwin-Williams

In other Sherwin-Williams news, SVP Mary L. Garceau sold 23,518 shares of Sherwin-Williams stock in a transaction that occurred on Monday, February 26th. The stock was sold at an average price of $322.66, for a total transaction of $7,588,317.88. Following the sale, the senior vice president now directly owns 28,475 shares of the company’s stock, valued at $9,187,743.50. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. In related news, SVP Mary L. Garceau sold 23,518 shares of the stock in a transaction that occurred on Monday, February 26th. The stock was sold at an average price of $322.66, for a total transaction of $7,588,317.88. Following the sale, the senior vice president now directly owns 28,475 shares in the company, valued at approximately $9,187,743.50. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, SVP Gregory P. Sofish sold 1,830 shares of the stock in a transaction that occurred on Friday, February 23rd. The stock was sold at an average price of $320.70, for a total value of $586,881.00. Following the sale, the senior vice president now owns 6,329 shares in the company, valued at $2,029,710.30. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 32,050 shares of company stock valued at $10,340,237. 0.60% of the stock is currently owned by corporate insiders.

Institutional Investors Weigh In On Sherwin-Williams

A number of large investors have recently bought and sold shares of the business. Vanguard Group Inc. grew its position in Sherwin-Williams by 0.8% during the 4th quarter. Vanguard Group Inc. now owns 21,435,960 shares of the specialty chemicals company’s stock worth $6,685,876,000 after acquiring an additional 179,274 shares during the last quarter. FMR LLC boosted its position in Sherwin-Williams by 65.4% in the 3rd quarter. FMR LLC now owns 5,427,014 shares of the specialty chemicals company’s stock valued at $1,384,160,000 after buying an additional 2,146,102 shares during the last quarter. Morgan Stanley boosted its position in Sherwin-Williams by 1.5% in the 3rd quarter. Morgan Stanley now owns 5,063,957 shares of the specialty chemicals company’s stock valued at $1,291,563,000 after buying an additional 75,571 shares during the last quarter. Capital World Investors boosted its position in Sherwin-Williams by 38.9% in the 4th quarter. Capital World Investors now owns 3,840,789 shares of the specialty chemicals company’s stock valued at $1,197,952,000 after buying an additional 1,075,351 shares during the last quarter. Finally, Norges Bank bought a new position in Sherwin-Williams in the 4th quarter valued at $1,176,356,000. 77.67% of the stock is currently owned by institutional investors.

About Sherwin-Williams

The Sherwin-Williams Company engages in the development, manufacture, distribution, and sale of paints, coating, and related products to professional, industrial, commercial, and retail customers. It operates through three segments: Paint Stores Group, Consumer Brands Group, and Performance Coatings Group.